Adverse Impact of MMF in AML/MDS Patients with High HCT-CI Receiving Matched Allogeneic Stem Cell Transplantation with PTCy-Based GvHD Prophylaxis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Jennifer Miatech, Rohtesh S. Mehta, Jeremy Ramdial, Gabriela Rondón, Gheath Alatrash, Yosra M. Aljawai, Amin Majid Alousi, Qaiser Bashir, George L. Chen, Chitra M. Hosing, Warren Benjamin Fingrut, Partow Kebriaei
+14 more Issa F. Khouri, David Marin, Yago L. Nieto, Amanda Leigh Olson, Betül Oran, Uday Popat, Muzaffar H. Qazilbash, Portia Smallbone, Samer A. Srour, Mark R. Tanner, Katy Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Rima M. Saliba
DOI: 10.1016/j.jtct.2025.12.366
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S257–S258
Publication date
1 February 2026
Language
EN